Toxicity of the bacteriophage λ cII gene product to Escherichia coli arises from inhibition of host cell DNA replication  by Ke̦dzierska, Barbara et al.
Toxicity of the bacteriophage  cII gene product to Escherichia coli
arises from inhibition of host cell DNA replication
Barbara Ke˛dzierska,a Monika Glinkowska,a Adam Iwanicki,a Michał Obuchowski,a
Piotr Sojka,a Mark S. Thomas,b and Grzegorz We˛grzyna,c,*
a Department of Molecular Biology, University of Gdan´sk, Kładki 24, 80-822 Gdan´sk, Poland
b Division of Genomic Medicine, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK
c Institute of Oceanology, Polish Academy of Sciences, S´w. Wojciecha 5, 81-347 Gdynia, Poland
Received 6 May 2002; returned to author for revision 5 July 2002; accepted 24 April 2003
Abstract
The bacteriophage  cII gene codes for a transcriptional activator protein which is a crucial regulator at the stage of the “lysis-versus-
lysogeny” decision during phage development. The CII protein is highly toxic to the host, Escherichia coli, when overproduced. However,
the molecular mechanism of this toxicity is not known. Here we demonstrate that DNA synthesis, but not total RNA synthesis, is strongly
inhibited in cII-overexpressing E. coli cells. The toxicity was also observed when the transcriptional stimulator activity of CII was abolished
either by a point mutation in the cII gene or by a point mutation, rpoA341, in the gene coding for the RNA polymerase  subunit. Moreover,
inhibition of cell growth, caused by both wild-type and mutant CII proteins in either rpoA or rpoA341 hosts, could be relieved by
overexpression of the E. coli dnaB and dnaC genes. In vitro replication of an oriC-based plasmid DNA was somewhat impaired by the
presence of the CII, and several CII-resistant E. coli strains contain mutations near dnaC. We conclude that the DNA replication machinery
may be a target for the toxic activity of CII.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The bacteriophage  CII protein is a crucial regulatory
protein involved in the “lysis-versus-lysogeny” decision at
an early stage of phage development in Escherichia coli
cells (for recent reviews, see Taylor and We˛grzyn, 1998;
We˛grzyn et al., 2001). This protein is a strong activator of
three phage promoters, pE, p1, and paQ, all of them being
essential in switching  development to the lysogenic path-
way. At each promoter CII recognises the sequence
TTGC(N)6TTGC overlapping the 35 region. The cII gene
product is unstable in vivo due to its rapid degradation by
the host-encoded HflB/FtsH protease (Herman et al., 1993).
HflB is partially inhibited by the phage  cIII gene product,
which is also a substrate for this protease (Herman et al.,
1997). In addition, CIII plays a more direct role in regula-
tion of CII activity, possibly as a specific molecular chap-
erone (Latala et al., 2001).
Apart from being a transcriptional activator, the CII
protein is highly toxic to host cells (Shimatake and Rosen-
berg, 1981; Rattay et al., 1984; Obuchowski et al., 1997a;
Gabig et al., 1998). One explanation for the mechanism of
this toxicity is that CII stimulates or represses expression of
certain E. coli genes by binding sequences matching the CII
DNA recognition sequence, thereby leading to the deregu-
lation of essential cellular processes. This could lead to
effective killing of bacterial cells shortly after induction of
cII gene expression. Indeed, mutations in the gene encoding
the  subunit of E. coli RNA polymerase (rpoB) were
isolated, which conferred resistance of the host strain to
killing by cII overexpression (Hammer et al., 1987). How-
ever, these mutants revealed unimpaired activation of CII-
dependent  promoters and normal cII gene expression, and
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most of them were defective in transcription termination
and antitermination. Therefore, it was not possible from
these results to identify the mechanism of CII toxicity.
In this work we aimed to identify cellular process(es)
affected by overproduction of the CII protein, which should
help us to understand the mechanism of CII toxicity. On the
basis of these experiments, we conclude that the mechanism
of CII toxicity is unlikely to be connected to its transcription
activation function. In contrast, our results suggest that the
toxic effect of CII appears to be specific for DNA replica-
tion.
Results
To identify cellular processes affected by overexpression
of the cII gene, we measured the synthesis of proteins,
RNA, and DNA in E. coli cells producing CII protein alone
or CII together with CIII (in both cases the results were very
similar). Bacterial cultures were pulse labeled with [35S]me-
thionine, [3H]uridine, or [3H]thymidine prior to induction of
cII expression and at different times after induction. We
found that protein synthesis was considerably inhibited in
cells producing CII, or CII, and CIII, 60 min after induction
(Fig. 1). However, this inhibition could be an indirect effect,
as such a phenomenon was not observed up to 30 min after
induction of cII and cIII expression, while the products of
these genes were abundant as early as 5 min after the
induction (data not shown, but see Fig. 3 in Obuchowski et
al., 1997b). Synthesis of total RNA was not significantly
affected by expression of cII even after 60 min of induction
(Fig. 2A). However, incorporation of [3H]thymidine into
TCA-precipitable material did decrease dramatically rela-
tively shortly (10–15 min) after induction of cII expression
(Fig. 2B). These results suggest that inhibition of DNA
replication may be the primary target of the toxic activity of
CII protein.
The CII-mediated inhibition of DNA replication might
be an indirect effect of CII- mediated changes in the ex-
pression of certain bacterial genes. To investigate the pos-
sibility that the activation function of CII is required for this
phenomenon, we used previously characterised CII and host
RNA polymerase mutants that abolish transcriptional acti-
vation by CII protein. It was demonstrated previously that
substitution of alanine by threonine at position 30 (A30T)
abolishes the CII activation function (Ho et al., 1988). This
alanine residue comprises part of the first helix in the helix-
turn-helix motif of CII, and it was concluded that this helix
is involved in nonspecific interactions of the cII gene prod-
uct with DNA. A plasmid analogous to that expressing the
wild-type cII gene, pMO23, but harbouring a G-to-A
change at nucleotide position 87 of the cII gene, leading to
substitution of an alanine codon by a threonine codon at
position 30, was constructed by site-directed mutagenesis
and named pMO23*. Impairment of the transcription acti-
vation function by CII protein may also be caused by spe-
cific mutations in the E. coli chromosome. The rpoA341
mutation results in a lysine-to-glutamate substitution at po-
sition 271 of the RNA polymerase  subunit (Thomas and
Glass, 1991). This mutation effectively abolishes transcrip-
tion activation by CII, most probably due to a defective
interaction between the cII gene product and the mutant
RNA polymerase (Obuchowski et al., 1997b), and also
results in impairment of activation of a number of other
positively regulated promoters (Giffard and Booth, 1988),
causes stimulation of expression of some genes (Gabig et
al., 2002), and impairs N-dependent transcriptional antiter-
mination (Obuchowski et al., 1997c).
Induction of expression of the wild-type cII gene results
in strong inhibition of bacterial growth (Fig. 3). We found
Fig. 2. Synthesis of RNA (A) and DNA (B) in E. coli WAM106 containing
plasmids pJMH1 and pMO22. Bacteria were grown in a minimal medium
at 30°C without (open circles) and with (closed circles) induction of cII
gene expression from pMO22 by addition of IPTG to final concentration of
1 mM at time 0. At the indicated times, RNA or DNA synthesis was
estimated by measurement of incorporation of [3H]uridine or [3H]thymi-
dine, respectively, during 1-min pulses as described under Materials and
methods. Similar results were obtained when plasmid pMO23 was used
instead of pMO22, or when the rpoA341 mutant (strain WAM105) was
used as a host, and when cultivation was performed at 43°C (data not
shown).
Fig. 1. Synthesis of E. coli proteins after induction of cII gene expression
from plasmid pMO22 and after induction of cII and cIII expression from
pMO23 in strain WAM106 containing plasmid pJMH1. Bacteria were
grown in a minimal medium at 30°C to OD575 of 0.2. IPTG was then added
at the concentrations indicated, and samples of equal cell mass were
withdrawn 60 min later. Following pulse-labeling (5 min) with [35S]me-
thionine (2 Ci ml1), samples were subjected to SDS–PAGE and auto-
radiography.
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that the presence of the A30T substitution in overproduced
CII had no effect on CII-mediated toxicity (Fig. 4A). Sim-
ilarly, an E. coli host strain harbouring the rpoA341 muta-
tion is only slightly less susceptible to the toxic effects of
CII overproduction (Fig. 4B). These results indicate that CII
toxicity is likely to be independent of the transcription
activation function of this protein.
Although CII is an activator protein, it can also act as a
repressor if the CII DNA binding site is appropriately po-
sitioned (Gussin et al., 1986). Thus, CII may repress bac-
terial genes where DNA sequences corresponding to the CII
recognition sequence overlap promoters or are located
downstream of promoters where a “roadblock” mechanism
could possibly operate (Deuschle et al., 1986; Pavco and
Steege, 1991; He and Zalkin, 1992). To investigate this
possibility, we performed an in silico analysis of the E. coli
genome and found that there are 294 sites fully matching the
CII-binding sequence, TTGC(N)6TTGC, distributed appar-
ently randomly around the genome (data not shown). In
most cases, these sites were located within gene coding
sequences, including those for genes whose products are
involved in DNA replication (dnaX) and other DNA-based
processes (exo, parE, recG, recR, dinD). Only 11 of the CII
recognition sites were identified upstream of coding se-
quences, where CII binding may potentially interfere with
transcription initiation. None of these sites were located
near promoters of essential genes. Therefore, we did not
identify an obvious target for CII-mediated inhibition of
transcription that would lead to an arrest of DNA replica-
tion. In addition, no CII-binding sites were found near oriC,
the origin of E. coli chromosome replication, which could
enable CII to directly interfere with DNA replication.
To investigate the mechanism of CII-mediated inhibition
of DNA replication, we examined the possibility that over-
expression of certain genes encoding components of the
DNA replication machinery could suppress the toxic effects
of CII. Accordingly, we found that overexpression of the E.
coli dnaB and dnaC genes together significantly suppressed
the growth inhibition resulting from CII overproduction
(Fig. 3). This suppression did not occur when dnaB or dnaC
was overexpressed separately (data not shown). Overex-
pression of other genes involved in DNA replication regu-
lation, dnaA and seqA, also did not alleviate CII toxicity
(data not shown). In our in silico analysis, no CII-binding
sites were found adjacent to or overlapping the dnaB and
dnaC genes (data not shown). Therefore, it seems unlikely
that CII influences transcription of these genes.
We asked whether amino acid substitutions in the CII
protein and the RNA polymerase  subunit which cause
impairment of CII-mediated transcription stimulation influ-
ence the alleviation of CII-dependent inhibition of bacterial
growth by overexpression of the dnaB and dnaC genes. We
found that overexpression of dnaB and dnaC improves
bacterial growth in the presence of CII in all experimental
systems tested (Fig. 4). Interestingly, this improvement was
most pronounced in the rpoA341 mutant (Fig. 4B).
To test whether CII inhibits DNA replication directly, we
examined the effects of this protein on in vitro replication of
a minichromosome (oriC-based plasmid DNA). For these
experiments we used a His-tagged derivative of CII which is
functional as a transcription activator in vitro (data not
shown). E. coli protein extracts (Fraction II) were added to
a reaction mixture containing purified CII and pBSoriC
plasmid DNA (Shotland et al., 2000). We found some in-
hibition of oriC-initiated DNA replication by CII protein in
this in vitro system, though the effect was not dramatic
(Fig. 5).
If CII inhibits DNA replication by interacting with the
replication machinery, particularly with DnaB and/or DnaC,
Fig. 4. Relative growth of E. coli rpoA (WAM106, panel A) and rpoA341
(WAM105, panel B) hosts bearing plasmids pMO23 (open circles),
pMO23* (open squares), pMO23 and pPS562 (filled circles), or pMO23*
and pPS562 (filled squares). All strains also harboured plasmid pJMH1.
Expression of the wild-type cII gene from plasmid pMO23 (circles) or a
mutant form encoding the A30T CII mutant from plasmid pMO23*
(squares) was induced by addition of IPTG to the concentrations indicated
at time 0 (at OD575 of bacterial culture  0.1). Expression of the dnaB and
dnaC genes from plasmid pPS562 was induced at 43°C (a shift of all
cultures from 30 to 43°C was performed at time 0). Relative bacterial
growth was calculated as the ratio of the increase of the OD575 of a given
culture in which expression of a cII allele was induced, to the increase of
the OD575 of the control culture, i.e., without induction of cII expression,
between 60 and 120 min after the induction. A value of 1.0 corresponds to
no observed growth inhibition.
Fig. 3. Growth of the E. coli strain WAM106 bearing plasmid pJMH1
(circles) and, in addition, plasmid pMO23 (squares), or plasmids pMO23
and pPS562 (triangles). Bacteria were cultured in LB medium at 43°C. In
experiments represented by open symbols, expression of the cII gene was
not induced, and in experiments represented by filled symbols, cII expres-
sion from plasmid pMO23 was induced by addition of IPTG to final
concentration of 0.1 mM at time 0. Expression of the dnaB and dnaC genes
from plasmid pPS562 was induced at 43°C (a shift of all cultures from 30
to 43°C was performed at time 0). Bacterial growth was monitored by
measurement of OD575 of cultures at the indicated times.
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it should be possible to isolate E. coli mutants in dnaB
and/or dnaC gene(s), revealing resistance to CII. Using a
series of strains bearing antibiotic-resistance markers located
at different positions in the E. coli chromosome (Singer et
al., 1989), we asked whether it is possible to isolate CII-
resistant mutants in dnaB and/or dnaC. Bacteria bearing a
plasmid with cII gene under ptac promoter (pMO23) and a
plasmid with lacIQ gene (pJMH1) were spread on plates
containing appropriate antibiotics (to ensure maintenance of
pMO23 and pJMH1), 1 mM IPTG (to induce cII overex-
pression), and a mutagen. When NQNO was used as a
mutagen at an amount of 10 g per plate, a few hundred
colonies could be obtained. To test if some of these mutants
bear changes in the dnaC locus, we used the CAG18619
strain, harbouring Tn10-kan at 99.5 min of E. coli genetic
map (zjj-3188::Tn10kan mutation). This locus is relatively
close to dnaC (99.1 min). In control experiments, dnaC1 (ts)
mutation was found to be 27% cotransducible with
zjj-3188::Tn10kan (data not shown). After obtaining CII-
resistant mutants of CAG18619, P1 transduction experi-
ments were performed, using MG1655/pMO23/pJMH1
strain as a recipient. Randomly selected transductants were
tested for CII-resistance by streaking colonies on plates
containing 1 mM IPTG (i.e., under conditions of CII over-
production). Seven of nine randomly selected mutants re-
vealed linkage (20–50% cotransduction) of kanamycin re-
sistance and CII resistance. We conclude that these seven
mutants are likely to contain mutations in dnaC. An analo-
gous selection using strain CAG18609 that bears the
malF3180::Tn10kan mutation, which is close to dnaB, did
not reveal any linkage of CII resistance to the transposon
(data not shown).
Discussion
The bacteriophage -encoded CII protein, a transcrip-
tional activator of phage lysogenic promoters, is highly
toxic to E. coli cells. It might seem likely that the lethal
effect of CII arises from overactivation of one or more
bacterial genes and subsequent disturbance of cell metabo-
lism. However, as we demonstrate in this article, the toxicity
of CII is not connected to its ability to stimulate transcrip-
tion initiation. Rather, our results suggest that CII toxicity
arises from an inhibition of host chromosome replication, as
DNA synthesis was strongly inhibited in cells expressing
cII, and overexpression of the dnaB and dnaC genes alle-
viated this inhibition significantly.
The dnaB gene codes for DNA helicase, which operates
in replication forks, and the dnaC gene product is respon-
sible for delivery of the DnaB helicase to the origin of
replication (oriC) region (for a review see Messer and
Weigel, 1996). This, in combination with the observation
that (i) overexpression of either dnaB or dnaC alone did not
alleviate CII toxicity and (ii) strong inhibition of DNA
replication was observed 10–15 min after induction of cII
gene expression, while CII protein was found in large
amounts in cells as shortly as 5 min after such an induction
(Obuchowski et al., 1997b, and data not shown) suggests
that the process of initiation of DNA replication may be
directly affected by CII.
The inhibition of protein synthesis, observed after induc-
tion of cII expression, could also result from changes in
some postinitiation steps in transcription. A decrease in the
activity of -galactosidase in cells expressing cII and har-
bouring the lacZ gene under control of CII-independent
promoters has been reported (Obuchowski et al., 1997a).
However, the inhibition of protein synthesis was consider-
ably delayed relative to the appearance of large amounts of
CII in cells. Moreover, overexpression of only two genes,
dnaB and dnaC, restored bacterial growth in the presence of
CII. Therefore, it seems more likely that the general inhi-
bition of protein synthesis in cells overexpressing cII may
be a secondary effect occurring in response to inhibition of
DNA replication.
Given the large number (294) of potential CII binding
sites present on the E. coli genome, one might argue that the
mechanism for the toxicity of overproduced CII most likely
involves binding of CII to one or more of these sequences.
Moreover, the absence of a requirement for the activation
function of CII may suggest that the toxic activity of CII
could result from transcription repression. However, the
almost immediate effect of CII overproduction on DNA
replication may point to a direct interference with the DNA
replication process. Transcription near the oriC region plays
an important regulatory role during initiation of E. coli
chromosome replication (Messer and Weigel, 1996). Al-
though the exact role of this transcription is not known, the
binding of a CII tetramer may interfere with this process
and, in turn, with DNA replication initiation. Replication of
bacteriophage  also requires transcription of the origin of 
DNA replication (ori), which appears to be required for
proper positioning of DnaB helicase (Taylor and We˛grzyn,
1995). Interestingly,  DNA replication is also inhibited
under conditions of enhanced expression of the cII gene
Fig. 5. Effect of CII protein on in vitro replication of an oriC-based
plasmid, pBSoriC. The reactions were carried out in E. coli Fraction II
extracts in the presence of the indicated amounts of histidine-tagged CII
protein (added to the reaction mixture before addition of Fraction II), as
described under Materials and methods.
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(Obuchowski et al., 1997a; Gabig et al., 1998). It is not clear
whether the mechanism of inhibition of  DNA replication
by CII is related to the mechanism of inhibition of host cell
DNA replication. Nevertheless, it is interesting that CII-
mediated inhibition of phage replication could be alleviated
by overproduction of  replication proteins, O (an initiator
protein) and P (a DnaC functional analog) (Obuchowski et
al., 1997a). However, as no CII-binding sites were found
near oriC in our in silico analysis, one might speculate that
CII could inhibit DNA replication by directly contacting the
replication machinery. Isolation of CII-resistant strains with
mutations localized in the dnaC gene region may support
this hypothesis. On the other hand, incomplete inhibition of
DNA replication by CII in vitro may suggest that the mech-
anism of CII-mediated toxicity is more complicated in vivo
and, as suggested above, it possibly involves interference
with transcriptional activation of the origin as well as in-
teraction with the replication machinery (note that the re-
quirement for transcriptional activation of the origin is strict
in vivo, whereas it may be negligible in vitro).
In summary, we have demonstrated that the replication
machinery may be a target for the toxic activity of CII, but
more detailed studies are necessary to understand the mo-
lecular mechanisms of CII-mediated inhibition of DNA
replication.
Materials and methods
Bacterial strains and plasmids
The E. coli strain WAM106 (F, araD139, (argF-
lac)U169, (his-gnd), thi, rpsL150, gltS0, flbB5301, relAI,
deoCI, rbsR) and its rpoA341 derivative, WAM105, were
described previously (Thomas and Glass, 1991). MG1655
wild-type strain (Jensen, 1993) and a series of strains bear-
ing antibiotic-resistance marker at different positions on the
chromosome (Singer et al., 1989) were employed. Strain
PC1 (leuB6, thyA47, deoC3, rpsL, dnaC1) was from our
collection. Plasmid pPS562, bearing the dnaB and dnaC
genes under control of the pR and pL promoters arranged in
tandem and conditionally repressed by a temperature-sensi-
tive cI857 gene product (Elvin et al., 1990), was used.
Plasmid pJMH1 (a pSC101-derived replicon bearing the
lacIq allele) has already been described (We˛grzyn et al.,
1992). Plasmids pMO22 (a p15A-derived replicon bearing
the cII gene under control of ptac) and pMO23 (a p15A-
derived replicon bearing the cII and cIII genes, each under
control of ptac) were described previously (Obuchowski et
al., 1997b). Plasmid pMO23* was constructed by introduc-
ing a G-to-A substitution at nucleotide position 87 of the cII
gene, according to the overlap extension method of site-
directed mutagenesis described by Ho et al. (1989). Internal
primers were P2502 (5-TGA GAA GAC AAC GGA AGC
TGT GGG) and P2503 (5-CCC ACA GCT TCC GTT
GTCTTC TCA), and external primers were PCB2 (5-TGG
CTG ATG GTG CGA TAG TC) and PCB7 (5-ACG TGC
GTC CTC AAG CTG). The integrity of the mutant cII gene
present in pMO23* was confirmed by DNA sequencing
according to Sambrook et al. (1989). Plasmid pBSoriC
(Konieczny and Liberek, 2002 and references therein) is a
minichromosome (oriC plasmid) that was used in this work
as a template in in vitro replication assays.
Estimation of bacterial growth rates
Bacterial strains were cultured in LB medium (Sambrook
et al., 1989) at the indicated temperatures in water bath
shakers. Samples of cultures were withdrawn at time inter-
vals; OD575 was measured, and the growth rate was calcu-
lated on the basis of growth curve analysis.
Estimation of efficiency of synthesis of proteins, RNA, and
DNA
Synthesis of proteins, RNA, and DNA was estimated by
measurement of incorporation of [35S]methionine, [3H]uri-
dine, or [3H]thymidine, respectively, during 5-min (labeling
with [35S]methionine) or 1-min (labeling with [3H]uridine
or [3H]thymidine) pulses according to a previously de-
scribed method (We˛grzyn et al., 1991). Briefly, bacteria
were cultured in a previously described minimal medium
(We˛grzyn et al., 1991); samples were withdrawn at the
indicated times and [35S]methionine or 3H-labeled nucleo-
sides ([3H]uridine or [3H]thymidine) were added up to 2 or
1 Ci ml1, respectively, for 1 or 5 min (see above). Then
samples were either boiled and subjected to SDS–polyac-
rylamide gel electrophoresis and autoradiography (labeling
with [35S]methionine) according to Sambrook et al. (1989)
or placed onto paper filters and transferred immediately to
ice-cold 10% TCA, washed in 5% TCA, then 1% TCA and
twice in 96% ethanol, and analyzed in a scintillation counter
(labeling with [3H]uridine or [3H]thymidine).
Purification of CII protein
Plasmid pET-CII (Shotland et al., 2000) was used for
overproduction of N-terminal His-tagged CII protein which
was purified as described previously (Shotland et al., 2000).
We proved that the purified his-tagged CII protein was
active as a transcription stimulator at the  pE promoter by
carrying out in vitro transcription assays (data not shown).
In vitro DNA replication assay
Replication of an oriC-based plasmid (pBSoriC) in vitro,
using a crude E. coli protein extract (Fraction II), was
examined as described by Konieczny and Liberek (2002).
Standard reactions contained 300 ng of plasmid pBSoriC
template and indicated amounts of the histidine-tagged CII
protein in the same volume of reaction buffer. The reactions
were carried out at 32°C for 60 min and were stopped by
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addition of an excess of trichloroacetic acid. Total radioac-
tive nucleotide incorporation was measured in a scintillation
counter following filtration onto Whatman GF/C glass fiber
filters, and the amount of synthesized DNA was calculated.
Isolation of CII-resistant mutants
Bacteria bearing plasmids pMO23 and pJMH1 were cul-
tivated in LB medium, and 0.1 ml of a culture was spread
onto an LB plate containing appropriate antibiotics, IPTG at
final concentration of 1 mM (to induce CII overproduction),
and a mutagen (the use of NQNO, 4-nitroquinolone-N-
oxide, at 10 g per plate, was the most effective method to
obtain CII-resistant mutants). Plates were incubated over-
night at 37°C, and colonies were used for mapping of
mutations.
Mapping of CII-resistance mutations
To test whether mutations causing CII-resistance are
located in dnaB or dnaC regions, strains bearing a kan
marker near dnaB or dnaC were used for isolation of CII-
resistant mutants as described above. Then, the obtained
mutants were used as donors in P1 transduction experiments
(performed according to Silhavy et al., 1984), in which
MG1655/pMO23/pJMH1 strain was a recipient. One hun-
dred transductants, selected for kanamycin-resistance, were
tested for CII-sensitive phenotype on LB plates containing 1
mM IPTG (thus overexpressing cII), and percentage of
cotransduction of kanamycin resistance and CII resistance
was calculated.
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